Actinic Keratosis Treatment Market Research Report Information By Type (Medications and Procedures), By End User (Hospitals & Oncology Centers, Dermatology Clinics and Ambulatory Surgical Center) - Forecast till 2032

1 Report Prologue

2 Market Introduction

2.1 Introduction 14

2.2 Assumptions & Limitations 14

3 Research Methodology

3.1 Research Process 17

3.2 Primary Research 17

3.3 Secondary Research 18

3.4 Market Size Estimation 18

3.4.1 Market Share Analysis 19

3.4.2 Market Pricing Approach 19

4 Market Dynamics

4.1 Introduction 21

4.2 Drivers 21

4.2.1 Increasing Prevalence Of Actinic Keratosis 21

4.2.2 Rising Demand And Acceptance Of Minimally Invasive Therapeutic Procedures 21

4.2.3 Suitable Medical Coverage For A Variety Of Treatment Options Available In The Market 22

4.2.4 Growing Geriatric Population 22

4.2.5 Drivers Impact Analysis 22

4.3 Restraints 23

4.3.1 High Cost Of Therapeutic Procedures 23

4.3.2 Risk Factors Associated With The Available Treatment Options In The Market 23

4.3.3 Restraints Impact Analysis 23

4.4 Opportunity 24

4.4.1 Growing Markets Of Asia-Pacific 24

4.5 Mega Trends 24

4.5.1 Application Of Cryosurgery In The Therapeutics Of Actinic Keratosis 24

4.6 Macroeconomic Indicator 24

4.7 Product Pipeline Analysis 25

4.7.1 Introduction 25

4.7.2 Aminolevulinic Acid Topical 20% Topical Solution, Device: BLU-U Blue Light Phototherapy Illuminator 25

4.7.3 Oleogel-S10 100 Mg/G, Placebo (Petroleum Jelly) 26

4.7.4 Aminolevulinic Acid-Based Photodynamic Therapy 26

4.7.5 Topical Steroid Ointment, Skin Barrier Moisturizer 27

4.7.6 Ingenol Mebutate Gel 0.015%, Ingenol Mebutate Gel 0.05% 27

4.7.7 SR-T100 Gel 28

4.7.8 Aminolevulinic Acid HCl 28

4.7.9 SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment 29

4.7.10 KX01 (Ointment) 29

5 Market Factor Analysis

5.1 Value Chain Analysis 31

5.1.1 R&D And Designing 31

5.1.2 Manufacturing 31

5.1.3 Distribution & Sales 31

5.1.4 Post-Sales Review 32

5.2 Porter’s Five Forces Model 32

5.2.1 Bargaining Power Of Suppliers 32

5.2.2 Bargaining Power Of Buyers 33

5.2.3 Threat Of New Entrants 33

5.2.4 Threat Of Substitutes 33

5.2.5 Intensity Of Rivalry 33

5.3 Investment Opportunities 33

5.4 Pricing Analysis 33

6 Actinic Keratosis Treatment Market, By Type

6.1 Introduction 35

6.1.1 Medications 36

6.1.2 Procedures 36

7 Actinic Keratosis Treatment Market, By End User

7.1 Introduction 38

7.1.1 Hospitals & Oncology Centers 39

7.1.2 Dermatology Clinics 39

7.1.3 Ambulatory Surgical Center 39

8 Global Actinic Keratosis Treatment Market, By Region

8.1 Introduction 41

8.2 Americas 42

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.2.1 North America 44

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.2.1.1 US 45

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.2.1.2 Canada 46

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.2.2 South America 47

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3 Europe 48

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1 Western Europe 50

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.1 Germany 51

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.2 France 52

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.3 UK 53

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.4 Italy 54

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.5 Spain 55

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.1.6 Rest Of Western Europe 56

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.3.2 Eastern Europe 57

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4 Asia-Pacific 58

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4.1 China 60

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4.2 India 61

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4.3 Japan 62

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4.4 Australia 63

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.4.5 Rest Of Asia-Pacific 64

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.5 Middle East & Africa 65

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.5.1 Middle East 67

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

8.5.2 Africa 68

Actinic Keratosis Treatment Market, By Type

Actinic Keratosis Treatment Market, By End User

9 Competitive Landscape

9.1 Introduction 70

10 Company Profiles

10.1 Biofrontera AG 72

10.1.1 Company Overview 72

10.1.2 Financial Overview 72

10.1.3 Products Offering 72

10.1.4 Key Developments 73

10.1.5 SWOT Analysis 73

10.1.6 Key Strategy 73

10.2 Cipher Pharmaceuticals Inc. 74

10.2.1 Company Overview 74

10.2.2 Financial Overview 74

10.2.3 Products Offering 75

10.2.4 Key Developments 75

10.2.5 SWOT Analysis 75

10.2.6 Key Strategy 75

10.3 BioLineRx. 76

10.3.1 Company Overview 76

10.3.2 Financial Overview 76

10.3.3 Products Offering 76

10.3.4 Key Developments 76

10.3.5 SWOT Analysis 77

10.3.6 Key Strategy 77

10.4 Valeant Pharmaceuticals. 78

10.4.1 Company Overview 78

10.4.2 Financial Overview 78

10.4.3 Products Offering 79

10.4.4 Key Developments 79

10.4.5 SWOT Analysis 79

10.4.6 Key Strategy 79

10.5 Leo Pharma 80

10.5.1 Company Overview 80

10.5.2 Financial Overview 80

10.5.3 Products Offering 81

10.5.4 Key Developments 81

10.5.5 SWOT Analysis 81

10.5.6 Key Strategy 81

10.6 Galderma SA 82

10.6.1 Company Overview 82

10.6.2 Financial Overview 82

10.6.3 Products Offering 82

10.6.4 Key Developments 82

10.6.5 SWOT Analysis 82

10.6.6 Key Strategy 82

10.7 Sun Pharmaceutical Industries Ltd 83

10.7.1 Company Overview 83

10.7.2 Products Offerings 84

10.7.3 Key Developments 84

10.7.4 SWOT Analysis 84

10.7.5 Key Strategy 84

10.8 3M 85

10.8.1 Company Overview 85

10.8.2 Products Offerings 85

10.8.3 Key Developments 86

10.8.4 SWOT Analysis 86

10.8.5 Key Strategy 86

10.9 Alma Lasers 87

10.9.1 Company Overview 87

10.9.2 Products Offerings 87

10.9.3 Key Developments 87

10.9.4 SWOT Analysis 87

10.9.5 Key Strategy 87

10.10 Stanford Chemicals 88

10.10.1 Company Overview 88

10.10.2 Financial Overview 88

10.10.3 Products Offering 88

10.10.4 Key Developments 88

10.10.5 SWOT Analysis 88

11 Conclusion

11.1 Key Findings 90

11.1.1 From CEO’s View Point 90

11.2 Key Companies To Watch 90

12 Appendix

12.1 Discussion Blue Print 92

13 List Of Tables

TABLE 1 ACTINIC KERATOSIS TREATMENT MARKET: PRODUCT PIPELINE ANALYSIS 25

TABLE 2 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 35

TABLE 3 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR MEDICATIONS 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR PROCEDURES 2020–2027 (USD MILLION) 36

TABLE 5 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR HOSPITALS & ONCOLOGY CENTERS 2020–2027 (USD MILLION) 39

TABLE 7 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR DERMATOLOGY CLINICS 2020–2027 (USD MILLION) 39

TABLE 8 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET FOR AMBULATORY SURGICAL CENTER 2020–2027 (USD MILLION) 39

TABLE 9 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2020–2027 (USD MILLION) 41

TABLE 10 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2020 (%) 41

TABLE 11 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2020–2027 (USD MILLION) 42

TABLE 12 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 43

TABLE 13 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 43

TABLE 14 NORTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 44

TABLE 15 NORTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 44

TABLE 16 US ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 45

TABLE 17 US ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 45

TABLE 18 CANADA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 46

TABLE 19 CANADA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 46

TABLE 20 SOUTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 47

TABLE 21 SOUTH AMERICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 47

TABLE 22 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2020–2027 (USD MILLION) 48

TABLE 23 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 49

TABLE 24 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 49

TABLE 25 WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 50

TABLE 26 WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 50

TABLE 27 GERMANY ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 51

TABLE 28 GERMANY ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 51

TABLE 29 FRANCE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 52

TABLE 30 FRANCE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 52

TABLE 31 UK ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 53

TABLE 32 UK ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 53

TABLE 33 ITALY ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 54

TABLE 34 ITALY ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 54

TABLE 35 SPAIN ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 55

TABLE 36 SPAIN ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 55

TABLE 37 REST OF WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 56

TABLE 38 REST OF WESTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 56

TABLE 39 EASTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 57

TABLE 40 EASTERN EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 57

TABLE 41 ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY COUNTRY 2020–2027 (USD MILLION) 58

TABLE 42 ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 59

TABLE 43 ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 59

TABLE 44 CHINA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 60

TABLE 45 CHINA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 60

TABLE 46 INDIA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 61

TABLE 47 INDIA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 61

TABLE 48 JAPAN ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 62

TABLE 49 JAPAN ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 62

TABLE 50 AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 63

TABLE 51 AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 63

TABLE 52 REST OF ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 64

TABLE 53 REST OF ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 64

TABLE 54 THE MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY REGION 2020–2027 (USD MILLION) 65

TABLE 55 THE MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 66

TABLE 56 THE MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 66

TABLE 57 THE MIDDLE EAST ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 67

TABLE 58 THE MIDDLE EAST ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 67

TABLE 59 AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020–2027 (USD MILLION) 68

TABLE 60 AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020–2027 (USD MILLION) 68

14 List Of Figures

FIGURE 1 MARKET STRUCTURE 15

FIGURE 2 RESEARCH PROCESS 17

FIGURE 3 DROC ANALYSIS OF THE GLOBAL ACTINIC KERATOSIS TREATMENT MARKET 21

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL ACTINIC KERATOSIS TREATMENT MARKET 22

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: GLOBAL ACTINIC KERATOSIS TREATMENT MARKET 23

FIGURE 6 VALUE CHAIN: GLOBAL ACTINIC KERATOSES TREATMENT MARKET 31

FIGURE 7 PORTERS FIVE FORCES MODEL: GLOBAL ACTINIC KERATOSES TREATMENT MARKET 32

FIGURE 8 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY TYPE 2020 & 2027 (USD MILLION) 36

FIGURE 9 GLOBAL ACTINIC KERATOSIS TREATMENT MARKET BY END USER 2020 & 2027 (USD MILLION) 38

FIGURE 10 AMERICAS ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2020 (%) 42

FIGURE 11 EUROPE ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2020 (%) 48

FIGURE 12 ASIA PACIFIC ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2020 (%) 58

FIGURE 13 THE MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET BY REGION MARKET SHARE 2020 (%) 65

FIGURE 14 GLOBAL ACITNIC KERATOSES TREATMENT, MAJOR PLAYERS MARKET SHARE ANALYSIS, 2020 (%) 70